Global Tissue Sectioning Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

China, the world\'s second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, May 11, 2021
Information
Tags: 
Science, Biotechnology, Research, Surgery, General Health, Health, Medical devices, Other Health, Trumpism, Draft:ByteBridge.io
Geotags: 
JAPAN, US, EUROPE, CHINA, INDIA, SOUTH KOREA, USA, AUSTRALIA, CANADA, GERMANY
Summary
Key Points: 
  • China, the world\'s second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.1% respectively over the 2020-2027 period.
  • These regional markets accounting for a combined market size of US$73.3 Million in the year 2020 will reach a projected size of US$98.7 Million by the close of the analysis period.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$87.6 Million by the year 2027.\n'


The "Tissue Sectioning - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Tissue Sectioning estimated at US$536.8 Million in the year 2020, is projected to reach a revised size of US$763.2 Million by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027.

Instruments, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$409.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Accessories & Consumables segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $158.2 Million, While China is Forecast to Grow at 4.8% CAGR

The Tissue Sectioning market in the U.S. is estimated at US$158.2 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Services Segment to Record 4.3% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$73.3 Million in the year 2020 will reach a projected size of US$98.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$87.6 Million by the year 2027.

Select Competitors (Total 33 Featured):

  • Leica Biosystems Nussloch GmbH
  • LLS ROWIAK LaserLabSolutions GmbH
  • Sakura Finetek Europe B.V.
  • Thermo Fisher Scientific

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 33

For more information about this report visit https://www.researchandmarkets.com/r/cxsa3c

Copyright: 
Copyright Business Wire 2021